VRTXON

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation.

Kripto AdıVRTXON

SıralamaNo.3709

Piyasa Değeri$0.00

Tamamen Seyreltilmiş Değer$0.00

Pazar Payı%

İşlem Hacmi/Piyasa Değeri (24 Sa)0.00%

Dolaşımdaki Arz0.35953858

Maksimum Arz0

Toplam Arz0.35953858

Dolaşım Oranı%

Arz Tarihi--

Varlığın ilk arz edildiği fiyat--

Tüm Zamanların En Yükseği466.35223147502205,2026-03-26

En Düşük Fiyat432.04959348516377,2026-03-27

Herkese Açık Blok ZinciriETH

HakkındaVertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation.

Sektör

Sosyal Medya

• Resmi Websitesi
• Blok Gezgini

etfindex:mc_etfindex_sourceYasal Uyarı: Veriler cmc tarafından sağlanmıştır ve yatırım tavsiyesi olarak değerlendirilmemelidir.